Disbelief Greeted Classics In Top U.K. Medical Journals

Truly innovative science is often— perhaps usually—accompanied by skepticism, dismissal, and/or disdane from the ranks of established expertise. That proposition receives surprisingly strong support from a study of the top-ranking papers from Britain’s premier medical journals. Data from the Institute for Scientific Information’s Science Citation Index (SCI) show that no less than four of the six papers most cited from The Lance: and the British Medical Journal during

Written byBernard Dixon
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Truly innovative science is often— perhaps usually—accompanied by skepticism, dismissal, and/or disdane from the ranks of established expertise. That proposition receives surprisingly strong support from a study of the top-ranking papers from Britain’s premier medical journals. Data from the Institute for Scientific Information’s Science Citation Index (SCI) show that no less than four of the six papers most cited from The Lance: and the British Medical Journal during the years 1955-1988 record ideas that were initially rejected or disbelieved.

In 1967, when Marina Seabright observed some strange stripes in a chromosome preparation she had made at Salisbury General Hospital, senior cytogeneticists dismissed the bands as artifacts. Seabright herself failed to reproduce the images too— even after adding instant coffee, in the hope that an accidental splash had provided the key ingredient. Four years later, however, she realized that the real secret was trypsin (which must have come from a contaminated ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies